The Challenge
A Tier-1 PE firm required deep technical vetting of a pre-revenue robotic surgery startup within a 72-hour exclusivity window. Traditional consultants lacked specific hands-on experience with the startup's proprietary haptic sensor array.
The Methodology
SignalBridge deployed Protocol 7 to identify and vet 4 former Lead Engineers from the target's primary competitor and 2 Chief of Surgery users who had participated in secret alpha trials.
The Outcome
The client identified a critical calibration flaw in the haptic feedback loop that would have delayed FDA approval by 18 months. The deal was restructured with a $40M valuation adjustment.
Solve Your Research Mandate
Leverage the same methodology to de-risk your next high-stakes investment decision.
Initialize Inquiry Desk